A manufacturer pharmacy channel and a compounded treatment program are different types of offer. Compare the exact product, prescription arrangement, payment total and included care. An active ingredient name does not establish product equivalence.
Trimi’s $99 semaglutide and $125 tirzepatide monthly equivalents require $1,188 and $1,500 upfront for twelve months. Its monthly plans are $175 and $235. The company now names BelieveRx and publishes a detailed refund policy; these disclosures do not independently verify a license, product or refund outcome. This update does not reverify NovoCare’s product-specific prices or savings eligibility; obtain its current quote before calculating a difference.
NovoCare Pharmacy
Novo Nordisk's direct-to-patient pharmacy for Wegovy and Ozempic
Trimi
Annual starting prices, separate monthly plans and a published refund policy
Where they actually differ
| NovoCare Pharmacy | Trimi | |
|---|---|---|
| Product status | Approved branded products should be checked against the specific product label and manufacturer offer. | Compounded preparations are not FDA-approved; FDA does not review them before marketing for safety, effectiveness or quality. |
| Price comparison | Confirm current product, route, dose, supply period, insurance and savings-program conditions. | Semaglutide monthly plan $175; twelve-month upfront total $1,188. These are different payment terms. |
| Prescribing and care | Confirm whether a separate clinician visit and ongoing follow-up are needed and what those services cost. | The offer includes provider access and a prescription if clinically appropriate. |
| Pharmacy and delivery | Confirm the actual dispensing channel and delivery arrangement for the prescribed branded product. | Trimi names BelieveRx and advertises overnight transit once compounded; review and preparation take separate time. |
Choose NovoCare Pharmacy if…
You and the clinician have identified an appropriate approved product and can establish the total cost of medication and follow-up under the current offer.
Choose Trimi if…
A clinician has identified a medical need for a particular compounded preparation that an approved product cannot meet, and you have reviewed the pharmacy, payment and cancellation terms. Price alone does not establish that need.
Bottom line
Do not calculate a universal saving from unlike products or an expired promotional price. Trimi’s annual commitment and compounded-product status both matter.
Frequently asked questions
Is compounded semaglutide interchangeable with an approved brand?
An ingredient name alone does not establish equivalence. Compounded preparations are not FDA-approved products; discuss the exact preparation with the clinician.
What does Trimi’s annual price include?
Its public offer states medication, supplies, provider access and shipping, with $1,188 upfront for twelve months of semaglutide.
Can this page establish my insurance or savings eligibility?
No. Verify the current manufacturer terms and your own coverage before relying on a quoted out-of-pocket price.
Sources checked for this update
Other comparisons
- CoreAge Rx vs Trimi — How do CoreAge Rx and Trimi compare on payment and cancellation terms?
- LillyDirect vs Amazon Pharmacy — Where should I fill a Zepbound prescription?
- Trimi vs TrimRx — How should you compare Trimi with a current TrimRx quote?
- Klinic vs DevotedDoc — Who will actually fight my insurance denial?
- Midi Health vs Alloy Women's Health — Which menopause-specialist GLP-1 programme is better value?
Medical disclaimer
This comparison is general information, not medical advice. GLP-1 medications are prescription drugs with serious potential risks and are not right for everyone. Talk to a licensed healthcare professional about your own medical history before starting, stopping, or changing treatment. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Pricing changes frequently — verify current rates directly. We may earn a commission from some links on this page; see our affiliate disclosure.
Date reviewed: August 3, 2026